In addition to hypoxic conditions in tumor tissues, selected genetic alterations in cancer cells also enhance HIF-1 activity, typically mutations in, or loss of, VHL gene in clear cell renal cell carcinoma [9],[11]. The gene discussed is HIF1A; the disease is neoplasm.